Jeff Boyd, PhD

Vice Chairperson
Jeff Boyd, PhD
Executive Director, Cancer Genome Institute
​Fox Chase Cancer CenterTemple University Health System
Philadelphia, Pennsylvania

​Jeff Boyd is professor and Robert C. Young, M.D., Chair in Cancer Research at the Fox Chase Cancer Center.  He earned a B.S. degree from Duke University in 1980 and a Ph.D. in toxicology and biochemistry from NC State University in 1986.  Following a postdoctoral fellowship in environmental pathology at the University of North at Chapel Hill, Dr. Boyd trained in the laboratory of Dr. J. Carl Barrett at the National Institute of Environmental Health Sciences, studying the molecular basis of tumor suppression.  He then established his own laboratory at the NIEHS/NIH, focusing on the genetics and molecular genetics of women's cancers, which has remained a career-long research interest.  Dr. Boyd left the NIEHS in 1994 to become an associate professor in the Departments of Obstetrics and Gynecology and Genetics at the University of Pennsylvania, establishing the Gynecologic Oncology Research Laboratory in the Division of Gynecologic Oncology.  He then rose to the rank of professor at the Memorial Sloan-Kettering Cancer Center, with appointments in the Department of Surgery, where he established the Gynecology and Breast Research Laboratory, and the Department of Medicine, where he directed the Diagnostic Molecular Genetics Laboratory.  In 2006, Dr. Boyd joined the Memorial University Medical Center in Savannah, GA, where he served as vice president of oncology and research and director of the Anderson Cancer Institute.  For the past six years, Dr. Boyd has served as a senior vice president at Fox Chase, first as chief scientific officer and then the founding executive director of the Cancer Genome Institute.  His clinical interests are in genomic medicine and molecular diagnostics, and his research interests remain in the areas of genetics and molecular genetics of women's cancers.  Dr. Boyd currently serves as chair of the Scientific Advisory Committee of the Ovarian Cancer Research Fund.